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Frank Q Nuttall1,2,3* and Mary C Gannon1,2Abstract
Background: We previously reported that a weight-maintenance diet with a carbohydrate:protein:fat ratio of
30:30:40%, ingested for 5 weeks, improved blood glucose control in subjects with untreated type 2 diabetes. In this
study we also determined that insulin and insulin-like growth factor-I (IGF-I) were increased. In this report we
provide further information. Specifically, 24-hour total and individual amino acids, glucagon and cortisol data are
provided. In addition, we determined whether these multiple effectors resulted in a positive nitrogen balance and
an increase in fat-free mass. Insulin and IGF-I should stimulate protein accumulation. An increase in amino acids,
particularly branched chain amino acids, should facilitate this, whereas glucagon and cortisol could have adverse
effects in this regard.
Methods: Eight men with untreated type 2 diabetes were studied. A randomized crossover design was used. Data
were obtained before and after 5 weeks on a control diet (55% carbohydrate:15% protein:30% fat) and on a 30%
carbohydrate:30% protein:40% fat diet. Nitrogen balance and body composition were determined at the beginning
and end of each dietary intervention.
Results: As expected, the mean 24-hour total amino acid area response was higher after ingesting the 30:30:40
diet. However, the increase was only statistically significant for the branched chain amino acids, and phenylalanine
and tyrosine. The 24-hour cortisol profile was unchanged. Glucagon was increased. Nitrogen balance was positive.
Body weight was stable. Body composition and computed tomography data indicate no change in the fat-free
mass.
Conclusion: This high protein, low carbohydrate diet induced a metabolic milieu which strongly favors a positive
protein balance, and a positive balance was present. However, an increase in lean (protein) mass was not
documented. Whether such a diet in people with type 2 diabetes is useful in preventing or delaying the loss of
total lean body mass and/or sarcopenia associated with aging remains to be determined.
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Glucagon, SarcopeniaBackground
We have designed diets referred to as Low Biologically
Available Glucose (LoBAG) diets. The general concept is
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distribution, and reproduction in any mediumthe elevated blood glucose in people with type 2 dia-
betes. The LoBAG diets are higher in protein and lower
in carbohydrate than those recommended by govern-
ment and professional organizations for the general
population. A subscript denotes the percent carbohy-
drate. Thus, a 30% carbohydrate diet is designated as
LoBAG30. In all of these diets the protein content is 30%
of food energy. When ingested over a 5-week period, a
LoBAG20 and LoBAG30 diet dramatically lowered the
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with type 2 diabetes [1-3]
In order to further evaluate the metabolic effects of
these diets we determined a number of metabolites and
hormones [4-6]. The insulin-like growth factor-I (IGF-I)
concentration was increased regardless of the carbohy-
drate content in variations of the LoBAG diet. Since the
protein content remained unchanged in all of these diets
(30%), we strongly suspect that the increased IGF-I is
due to the increased dietary protein content.
The circulating IGF-I concentration is under control of
growth hormone (GH) and circulates largely bound in a
ternary complex of IGF-I, IGF-Binding Protein 3 (IGFBP-3)
and a protein referred to as the Acid-Labile Subunit (ALS).
In addition, free IGF-I may be partially regulated acutely by
the concentration of IGF-Binding Protein-1 (IGFBP-1). The
IGFBP-1 concentration is negatively regulated by insulin.
Therefore, we previously evaluated the effect of a LoBAG30
diet on GH, IGF-I, IGFBP-3, IGFBP-1, and ghrelin [3].
Ghrelin was measured since it can bind to the GH receptor.
It also may be involved in food intake regulation [7,8].
IGF-I increased ~30%, was stable, and independent
of a change in GH or IGFBP-3. IGFBP-1 was inversely
related to the insulin concentration [3]. The increase
in IGF-I and insulin, and decrease in IGFBP-1 theoret-
ically could have a strong anabolic effect, and result in
an increase in fat-free mass (FFM). An increase in
branched-chain amino acids (BCAAs) derived from the
higher dietary protein also could stimulate protein syn-
thesis [9]. However, this could be offset by elevated
cortisol and glucagon concentrations [10-13].
We report here additional data from the study in which
we previously reported the GH, IGFBPs, insulin and ghre-
lin data [3]. Specifically, the effect of ingestion of a
LoBAG30 diet over a 5-week period on the 24-hour circu-
lating total alpha amino acid nitrogen (AAN) (total amino
acids), individual specific amino acids, cortisol, and gluca-
gon concentrations is presented. The 24-hour urinary free
cortisol was determined as were a number of other circu-
lating and urinary metabolites. The amount of nitrogen
ingested during 24 hours and the average of a 4-day fecal
nitrogen excretion, as well as 24-hour urinary nitrogen
also were quantified. In addition, body composition data
were obtained using 4 different methods.
In the aging United States population with and with-
out diabetes, loss of bone and muscle mass, resulting in
increased frailty, falls, hip fractures, etc, is a major prob-
lem, and an economic burden for the health care system.
We posited that if we can demonstrate a positive protein
balance, an increase in fat-free mass without a change in
weight, and without deleterious effects, a LoBAG diet
could have beneficial effects far beyond control of blood
glucose in older subjects with type 2 diabetes, and po-
tentially for others as well.Methods
Nine male subjects with type 2 diabetes were recruited
and screened, as reported previously [2]. Some subjects
had been taking oral hypoglycemic medications before
enrollment. These were discontinued for varying periods
of time to allow the glycated hemoglobin to stabilize be-
fore the study was begun. All subjects signed consent
forms and all also obtained approval from their primary
care provider before discontinuing their medications.
Other medications were continued and remained un-
changed during the study. The study was approved by
the VA Medical Center and University of Minnesota
Committees on Human Subjects.
Eight subjects completed the study. One individual
participated in a humanitarian aid project during the
washout period. He lost a considerable amount of weight
during this time, and thus did not complete the second
arm of the study. Patient characteristics have been pre-
sented previously [3].
A six-day rotating menu was used which was calcu-
lated to consist of 30% carbohydrate (low starch), 30%
protein, 40% fat (10% saturated fat) (LoBAG30) or a con-
trol diet (55% CHO, 15% protein, 30% fat) [2,3]. The
diets contain foods typical of those consumed by our
patients. Total food energy was individualized to insure
that each subject remained weight stable during the
study. Dietary preferences were accommodated when-
ever possible. All food was provided to the subjects.
Protocol
A randomized, crossover, 5 week design with a washout
period was used. The age of the subjects ranged from 52
to 70 years. The glycated hemoglobin ranged from 7.1 to
11.4%, with a mean of 8.8%. Subjects were instructed to
continue their current activity level during the study. To
our knowledge, based on subject interviews, these
instructions were followed. The protocol has been
described previously [3,6]. Briefly, subjects are admitted
to the Special Diagnostic and Treatment Unit (SDTU,
similar to a Clinical Research Center) at the beginning
and end of each 5-week diet arm. The menu for the con-
trol diet that was ingested during the 24-hour data col-
lection period was identical for each of three 24-hour
time periods (pre and post control and pre-LoBAG).
The LoBAG30 menu was specific for the day of the 6-
day menu rotation at which the subject underwent the
24-hour blood draw. Meals were fed at 0800 (breakfast),
1200 (lunch), and 1800 (dinner) with a snack at 2100 hr.
Blood was obtained at 0730, 0745 and 0800, 15 and
30 minutes after each meal, then at 30 minute intervals
for the next 2 hours and finally, hourly until the next
meal, for a total of 46 time points for AAN, glucagon
and cortisol. Samples for individual amino acids were
obtained over 18 hours (3 baseline samples at 0730,
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0900, 1000, 1200, 1400, 1800, 2100, 0200 hr). Urine (24
hr) was collected for determination of free cortisol,
microalbumin, calcium, creatinine, glucose, pH, potas-
sium, sodium, urea and uric acid. Four day complete
fecal specimens were collected with the last day being
the day of the 24-hr blood draw.
Although the control diet and the LoBAG30 diet were
generally isocaloric for each individual subject, the
LoBAG30 meals were perceived to contain more (“too
much”) food. Both diets were readily accepted by the
subjects.
Analytical methods
Plasma and/or urine creatinine, urea nitrogen, sodium,
potassium, glucose, uric acid, total cholesterol, HDL-
cholesterol, triacylglycerol, pre-albumin and albumin,
were determined by an automated method on an Ortho-
Clinical Diagnostics Vitros 950 analyzer (Raritan, NJ);
LDL cholesterol was calculated with the Friedwald
formula; microalbumin was determined using a
Beckman-Coulter Array 360 analyzer; urinary calcium
and magnesium were determined colorimetrically on a J
& J Vitros Instrument (J & J Engineering, Poulsbo, WA).
Glucagon was determined by radioimmunoassay using
kits purchased from Linco Research (purchased by Milli-
pore, Billerica, MA). AAN, a measure of the total amino
acids, was determined by an O-phthaldialdehyde dye
binding method (Gusmer Enterprise, Inc Waupaca, WI).
Individual amino acid concentrations were determined
by high-performance liquid chromatography (ion
exchange) using precolumn online derivatization with
O-phthalaldehyde and 3-mercaptopropionic acid and 9-
fluorenylmethylchloroformate followed by ultraviolet de-
tection. Serum cortisol was determined by Abbott
AxSym, based on a Fluorescence Polarization Immuno-
assay (Abbott Park, IL.). Urinary free cortisol initially
was determined in the laboratory of Dr. B. Pearson-
Murphy using a high-performance liquid chromatog-
raphy purification step followed by a cortisol-binding
assay (n = 4). Subsequently it has been done by liquid
chromatograph, tandem mass spectrometry (LC MS/
MS) at Quest, (San Juan Capistrano, CA) (n = 3). It was
not determined in one subject.
To determine protein balance, the macronutrient, in-
cluding protein, content of the meals was calculated
using Nutritionist Pro version 2.0 (First data bank:
Hearst Corporation, San Bruno, CA). The amount of ni-
trogen present in the protein was calculated using 5.53 g
nitrogen/g protein [14]. The total amount of protein de-
aminated was determined by quantifying the nitrogen in
urine urea nitrogen, creatinine and uric acid excreted
over the 24-hrs of the study, the measured nitrogen lost
in the feces, and the amount of urea nitrogen retainedendogenously. The latter was calculated by determining
the difference in plasma urea nitrogen concentration be-
tween the fasting baseline at the beginning and at the
end of each 24-hour study period, and correcting for
plasma water by dividing by 0.94. In this calculation it is
assumed that there is a relatively rapid and complete
equilibration of urea in total body water. Total body
water as a percentage of body weight was calculated
using the equation of Watson et al. [15]. The overall as-
sumption is that a change in plasma urea concentration
is indicative of a corresponding change in total body
water urea concentration. The above calculations did
not account for urinary ammonia, amino acids or hip-
puric acid, which have been reported to result in 1.5 g
nitrogen excreted/100 g protein ingested [14]. The
grams of nitrogen metabolized have been increased
accordingly.
To determine nitrogen balance directly, the nitrogen
content of the meals was quantified. Meals for each of
the 6 days of the LoBAG30 diet, and the one-day of the
Standard diet were prepared based on a 2700 Kcal diet
and homogenized individually in a Heavy Duty Com-
mercial Warring Blender. Two aliquots for each day
were analyzed for nitrogen by thermal conductivity after
combustion in an oxygen-rich atmosphere at 850°C.
(University of Minnesota Analytical Research Labora-
tory). Total urinary nitrogen and fecal nitrogen were
determined by the Dumas combustion method in the
Mayo Clinic Laboratories (Rochester, MN). The amount
of urea nitrogen retained in the body water was calcu-
lated by determining the difference in plasma urea nitro-
gen concentration between the fasting baseline at the
beginning and at the end of each 24-hour study period,
and correcting for plasma water by dividing by 0.94, as
above. Total body water was measured directly [16].
Fat-free mass was determined using 3 different techni-
ques, bioelectric impedance, (RJL Systems, Clinton
Township, MI), tritiated water dilution [16] (3H2O from
Perkin Elmer, Boston, MA) and Dual-Energy X-Ray Ab-
sorptiometry (DEXA), Luna Prodigy DEXA scanner (GE
Healthcare, Waukesha, WI). In addition, computed tom-
ography (CT) scans were taken of the abdomen at the
level of the L2-L3 interspace and both thighs midway
between the iliac crest and the superior margin of the
patella in a sitting position at baseline and week 5. Ori-
ginally a 7.5 mm CT slice was taken. Subsequently the
CT scanner was changed and slice thickness was
reduced to 6 mm. Data were sent to Dr. Michael Jensen’s
laboratory at the Mayo Medical School and Clinic for
analysis. Subjects were identified by number only, thus
this analysis was done blinded.
For quantification of 24-hour plasma/serum data, net
24-hour incremental area responses were calculated
using the overnight fasting value as baseline. Total 24-
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baseline. Both area calculations were done using a com-
puter program based on the trapezoid rule [17]. Statis-
tics were determined by Student's t test for paired
variates, comparing the results following 5 weeks on a
control diet with those following 5 weeks on a LoBAG30
diet. Data are presented as means ± SEM. Prism 4 soft-
ware was used (Graphpad Software, Inc. San Diego, CA)
for the iMac computer (Apple, Cupertino, CA).
Results
Fasting AAN concentrations were similar before and
after 5 weeks on a control diet, and before and after 5
weeks on a LoBAG30 diet (Figure 1). Integrated net area
responses were similar before and after 5 weeks on the
control diet, but were significantly increased followingFigure 1 24 Hour Serum Alpha Amino Nitrogen (AAN) Response (Top
line represents the mean AAN response at the beginning of the study, whi
The closed triangles, solid line represents the AAN response after 5 weeks
AAN response at the beginning of the test arm of the study while ingestin
circles, solid line represents the AAN response after 5 weeks of ingesting a
The inserts indicate the mean net 24-hour integrated AAN area response p
(bottom), using the fasting value as a baseline. * indicates statistical signific5 weeks on a LoBAG30 diet, as expected (P< 0.006)
(Figure 1 inserts). Integrated total area responses, using
zero as baseline, were not statistically different before
(115 ± 3 mg.hr/dl) and after 5 weeks (124 ± 2 mg.hr/dl)
on a control diet or before (122 ± 5 mg.hr/dl) and after
5 weeks on a LoBAG30 diet (124 ± 3 mg.hr/dl) (data not
shown).
Integrated 18-hour individual amino acid data before
and after being on the control diet and before and after
being on the LoBAG diet were determined. In some
cases the amino acid concentration was still elevated at
18 hours. The concentration at the 18-hour time point
was extrapolated to the fasting baseline to represent the
24-hour time point. The foods ingested during the first
24-hour period of the LoBAG arm were the same as
those ingested at the beginning and end of the control– control diet) (Bottom – LoBAG30 diet). The open triangles, broken
le ingesting a control diet of 55% carbohydrate, 15% protein, 30% fat.
of ingesting a control diet. The open circles, broken line represents the
g a control diet of 55% carbohydrate, 15% protein, 30% fat. The closed
LoBAG30 diet consisting of 30% carbohydrate, 30% protein, 40% fat.
re- and post 5 weeks after ingesting a control (top) or LoBAG30 diet
ance (P = 0.006).
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drawn over a 24-hour period, the same foods were pro-
vided. Thus, these data have been combined with the
control diet data. That is, the control diet data obtained
on the 3 occasions have been averaged and compared
with the post LoBAG diet data. Nineteen amino acids
were quantified. Data for 12 amino acids are presented
in Table 1. Data for the other amino acids (aspartate,
cysteine, glutamate, histidine, methionine, threonine,
tryptophan) are not listed because they are quantitatively
minor. In addition, their concentrations did not change.
There was considerable variation in all of the results. A
statistically significant increase was observed for phenyl-
alanine, tyrosine and the BCAAs. The increase for each
BCAA was 5 fold or greater. This also was true for
phenylalanine. Leucine increased the most (12 fold).
The fasting serum cortisol concentrations were similar
before and after 5 weeks on the control diet and before
and after 5 weeks on the LoBAG30 diet (Figure 2). The
post LoBAG (11.3 μg/dl) is not significantly higher
(P = 0.184). The concentration decreased from 0800 to a
nadir at 2200–2400 hr. It subsequently increased to
reach the 0800 hr value again (Figure 2). Neither the
integrated net (Figure 2 inserts) nor total area (data not
shown) responses were statistically different.
The fasting plasma glucagon concentrations were
similar before and after 5 weeks on a control, or on a
LoBAG30 diet (Figure 3). The integrated net (Figure 3 in-
sert) (210 ± 111, 226 ± 96 and 133 ± 158 pg hr/ml) andTable 1 Individual amino acid area response using the
average of the three control days μMol.hr/L






Alanine 1203± 283 1645± 330 1284± 297 1742± 348
Arginine 23 ± 106 212 ± 165 8 ± 116 200 ± 204
Asparagine 89 ± 31 212 ± 70 100± 32 258 ± 86
Glycine 34 ± 90 45 ± 109 38 ± 93 121 ± 115
Isoleucine 115± 66 568 ± 63* 133± 74 679 ± 82*
Leucine 79 ± 103 966 ± 119* 85 ± 111 1144± 149*
Lysine 172± 125 548 ± 121 188± 147 596 ± 122
Phenylalanine 38 ± 37 225 ± 55* 26 ± 42 259 ± 67*
Proline 739± 101 880 ± 107 800± 113 969 ± 137
Serine 2 ± 43 28 ± 79 -30 ± 53 40 ± 99
Tyrosine 617± 268 1227± 266* 652± 301 1454± 342*
Valine 163± 143 1414± 175* 168± 161 1705± 220*
Values are mean ± SEM. * indicates statistically significantly different from the
respective control (P< 0.05) based on Student’s t test. Samples were obtained
over an 18-hour time period. In some cases the concentration was still
elevated at 18 hrs. The concentration from the 18-hour time point was
extrapolated to the fasting baseline to represent the 24-hour time point.
Those data are presented as “extrapolated” 24-hour data.total area responses (2501 ± 276, 2309 ± 303, 2455 ± 235
pg hr/ml) were similar before and after the control diet
and before the LoBAG30 diet, respectively. However,
both the integrated net (708 ± 115 pg hr/ml) and total
(2958 ± 249 pg hr/ml) (not shown) glucagon area
responses were significantly increased while on the
LoBAG30 diet (p = 0.03 and p= 0.01, net and total area
responses, respectively).
Blood pressure, serum creatinine, uric acid, albumin,
pre-albumin and HDL cholesterol were unchanged after
5 weeks on either the control or the LoBAG30 diet
(Table 2). Total and LDL cholesterol were significantly
decreased after 5 weeks on the LoBAG30 diet. Triglycer-
ides were significantly decreased after 5 weeks on either
diet.
Urinary excretion of sodium, urea nitrogen, uric acid,
creatinine, and the creatinine clearance, as well as the
urinary free cortisol all were significantly increased fol-
lowing 5 weeks on a LoBAG30 diet compared to the pre-
5 week baseline. Urine volume, potassium and calcium
were similar before and after either the control or the
LoBAG30 diet (Table 3).
The 24-hour fecal nitrogen excreted before and after 5
weeks on a control diet and before 5 weeks on a LoBAG30
diet was similar (1.6 ± 0.2, 1.7 ± 0.2, and 1.7 ± 0.3 g/day,
respectively). It was significantly greater after 5 weeks
on a LoBAG30 diet (2.2 ± 0.3 g/day p = 0.04).
Calculated protein balance
The protein balance (Table 4, A) during the 24-hour
study periods at the end of each 5-week period was cal-
culated as we have done before [5,6] with the following
exceptions. Previously, only the nitrogen in urine urea
was accounted for. In the present study the nitrogen
contribution of urine creatinine and uric acid also were
included. Also, fecal nitrogen was determined directly,
and a correction was made for excreted ammonia, amino
acids, and hippuric acid (1.5 g) [14].
On the first and the last day of the 5 weeks on the
control diet, the calculated protein ingested based on
published data (Nutritionist Pro, version 2.0) was
94.2 ± 5.1 g and 98.0 ± 5.0 g, respectively. The metabo-
lized protein was accounted for by calculation of 1) re-
tention of urea nitrogen in body water, 2) the nitrogen
measured in urine urea, creatinine and uric acid, and 3)
the nitrogen contribution from ammonia, amino acids,
and hippuric acid [14]. The calculated values at the be-
ginning and end of the control diet were 88.5 ± 6.7 g and
93.5 ± 5.4 g, (94 and 96%) respectively. When ingesting
the control diet on the first day of the LoBAG30 arm of
the study, 98.2 ± 4.0 g of protein was calculated to have
been ingested and 100.1 ± 6.4 g was accounted for by
retained urea nitrogen and that excreted in urine and
feces (102%). After 5 weeks on the LoBAG30 diet, the
Figure 2 24 Hour Serum Cortisol Response (Top – control diet) (Bottom – LoBAG30 diet). The open triangles, broken line represents the
mean cortisol response at the beginning of the study, while ingesting a control diet of 55% carbohydrate, 15% protein, 30% fat. The closed
triangles, solid line represents the cortisol response after 5 weeks of ingesting a control diet. The open circles, broken line represents the cortisol
response at the beginning of the test arm of the study while ingesting a control diet of 55% carbohydrate, 15% protein, 30% fat. The closed
circles, solid line represents the cortisol response after 5 weeks of ingesting a LoBAG30 diet consisting of 30% carbohydrate, 30% protein, 40% fat.
The inserts indicate the mean net 24-hour integrated cortisol area response pre- and post 5 weeks after ingesting a control (top) or LoBAG30 diet
(bottom), using the fasting value as a baseline.
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146.5 ± 4.3 g were accounted for by metabolism (75%).
Thus, the calculated protein actually ingested was simi-
lar for all 3 control diets, as expected. The nitrogen bal-
ance was essentially neutral on these control diets
(mean = 97%). In contrast, when the LoBAG30 diet was
ingested, the protein balance clearly was positive
(Table 4, A) (P = 0.01).
Measured nitrogen (protein) balance
When the actual nitrogen content of the food was deter-
mined by a thermal conductivity method, the mean total
nitrogen content in the control diets was similar to that
calculated (Table 4 B vs A). Although there are numer-
ous nitrogen containing compounds in food, other thanprotein [18], these are present in relatively small
amounts in food. [19-21]. Interestingly, the determined
nitrogen content of the LoBAG30 diet was lower than
the value calculated based on protein intake (31.8 g vs
35.4 g, respectively, Table 4 B vs A).
During the review process of the manuscript, one Re-
viewer pointed out that if the factor 6.25 is used in the
conversion of nitrogen to protein, the calculated protein
intake is 31.3 g, which makes the value very similar to
the 31.8 g measured. The increase in dietary protein in
the LoBAG diet was largely due to an increase in meat
protein. The traditional calculated nitrogen in meat is
16% (6.25), rather than 19% (5.53). These factors (6.25
and 5.53) were used to calculate the protein, based on
nitrogen measured.
Figure 3 24 Hour Plasma Glucagon Response (Top – control diet) (Bottom – LoBAG30 diet). The open triangles, broken line represents the
mean glucagon response at the beginning of the study, while ingesting a control diet of 55% carbohydrate, 15% protein, 30% fat. The closed
triangles, solid line represents the glucagon response after 5 weeks of ingesting a control diet. The open circles, broken line represents the
glucagon response at the beginning of the test arm of the study while ingesting a control diet of 55% carbohydrate, 15% protein, 30% fat. The
closed circles, solid line represents the glucagon response after 5 weeks of ingesting a LoBAG30 diet consisting of 30% carbohydrate, 30% protein,
40% fat. The inserts indicate the mean net 24-hour integrated glucagon area response pre- and post 5 weeks after ingesting a control (top) or
LoBAG30 diet (bottom), using the fasting value as a baseline. * indicates statistical significance (P = 0.03).
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considerably higher than the actually measured nitrogen
in the food ingested for the Control-Pre, Control-post
and LoBAG-Pre data sets (Table 4B). The reason for this
is unexplained. However, it should be noted that a differ-
ent method was used in the determination of the fecal
and urine nitrogen compared to food nitrogen
(Table 4B).
The determined nitrogen data (Table 4B) resulted in a
markedly negative protein balance when the subjects
ingested the control diet, as reported previously by
others [22]. Nevertheless, both for the calculated as well
as the measured nitrogen balance, the balance was posi-
tive for the LoBAG30 diet. Indeed the difference from
the average percent of protein metabolized of the three
control diets (Control pre, Control – post, LoBAG –pre) and the LoBAG post, was nearly identical, whether
protein balance was determined by method A (Mean
97 – 75 =Δ22%) or method B (Mean 116 – 92 =Δ 24%)
Overall the data clearly indicate a relative difference in
nitrogen balance when the subjects ingest a LoBAG30
diet compared to the control diet.Body composition
Body composition data are presented in Table 5. Sub-
jects total body weights were similar before or after
ingesting either diet. The fat-free mass (FFM) obtained
by DEXA correlated well with the tritium dilution data,
but both were lower than with Bioelectric Impedance.
The mean FFM was similar before and after ingesting
the control or the LoBAG diet.
Table 2 Caloric Intake, Blood Pressure, Plasma/Serum
Metabolites
Control-Pre Control-Post LoBAG-Pre LoBAG-Post
Caloric Intake 2513± 135 2613± 134 2619± 106 2612± 144
Blood Pressure
Systolic 140 ± 9 134 ± 9 139 ± 4 131± 6
Diastolic 83 ± 4 78 ± 3 78± 3 78± 4
Creatinine (mg/dl) 1.0 ± 0.05 1.0 ± 0.06 1.0 ± 0.05 1.0 ± 0.07
Cholesterol (mg/dl) 156 ± 14 134 ± 8 166 ± 12 140± 12 *
HDL (mg/dl) 39 ± 2 35 ± 2 36± 2 35± 2
LDL (mg/dl) 92 ± 10 80 ± 6 102 ± 12 86 ± 10 *
Triglycerides
(mg/dl)
142 ± 24 94 ± 12 * 138 ± 19 97 ± 17 *
Serum Uric Acid
(mg/dl)
5.2 ± 0.4 4.7 ± 0.3 5.1 ± 0.3 5.0 ± 0.4
Albumin (mg/dl) 4.5 ± 0.05 4.4 ± 0.08 4.4 ± 0.07 4.4 ± 0.07
Pre albumin 25.0 ± 1.3 24.3 ± 1.1 25.3 ± 1.3 24.7 ± 1.0
Both Control and LoBAG diets were designed to contain ~10% saturated fatty
acids.
Values are Means ± SEM.
Statistics were done using Student’s t test comparing Control-Pre with Control-
Post and LoBAG-Pre with LoBAG-Post. * p≤ 0.05.
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urement of FFM (particularly muscle mass) [23], it was
significantly increased. The increase could not be
explained by the creatine/creatinine or uric acid derived
from the additional meat and other protein sources in
the diet [24]. It also could not be attributed to the in-
crease in creatinine clearance since the mean plasma
creatinine was unchanged. Also, creatinine, like urea,Table 3 Urine Data (n = 8)
Control- Pre
Volume (ml) 4171± 654
Glucose (g) 10 ± 6
Potassium (m atoms) 91 ± 10.8
Sodium (m atoms) 188± 15
Urea Nitrogen (g) 13.6 ± 1.1
Uric Acid (g) 0.74 ± 0.04
Urine Nitrogen
(Urea, Creat, Uric Acid only)
14.5 ± 1.1
Micro albumin (mg) < 5
Cortisol (μg) ( n = 6) 17.9 ± 4.8
Calcium (g) 263± 30
Creatinine (g) 1.8 ± 0.09
Creatinine Cl (ml/min) 128± 10
pH 5.9 ± 0.2
Values are mean ± SEM.
Statistics were done using Student’s t test comparing Control – Pre with Control – P
* = P< 0.05 using Student’s t test compared to Pre;
~ P = 0.06 using Student’s t test, and P= 0.008 using Wilcoxon’s sign rank test.rapidly diffuses throughout body water and is not an
issue.
The CT data also indicated no change in visceral, total
abdominal or thigh fat and no change in thigh muscle
area.
Discussion
As indicated previously, a LoBAG diet theoretically
could result in a positive protein balance and an increase
in FFM for several reasons. First, the postprandial insu-
lin response to the LoBAG30 diet is vigorous [3] and in-
sulin is reported to decrease whole body protein
degradation and possibly stimulate protein synthesis
[9,25,26], although this effect is blunted in men with
type 2 diabetes [27].
Second, total IGF-I is increased by ~ 30% and free
IGF-I is likely to be increased further because of a
marked decrease in IGFBP-1 associated with meal inges-
tion [3]. That the total IGF-I was increased but IGFBP-3
was not [3] also suggests that the additional IGF-I was
either bound to other IGF-I binding proteins [3] and/or
the free IGF-I was markedly elevated when the subjects
were ingesting the LoBAG diet.
The effect of IGF-I on protein anabolism has been
reported to occur only at high and perhaps unphysio-
logical concentrations, and was attributed to its insulin-
mimetic activity [28]. However, others have clearly
reported that IGF-I stimulates skeletal muscle protein
synthesis at physiological levels, an effect independent of
its insulin-like effect [9].
In addition, IGF-I is reported to not only stimulate
protein synthesis and to accelerate amino acid clearanceControl -Post LoBAG-Pre LoBAG-Post
3889± 875 4671± 655 4500± 581
7 ± 3 16 ± 8 3 ± 2 ~
78 ± 7.6 103 ± 11.8 98 ± 5.6
211 ± 20 201 ± 15 273 ± 15 *
13.4 ± 0.9 15.8 ± 1.0 22.5 ± 0.7 *
0.69 ± 0.03 0.74 ± 0.05 0.90 ± 0.03 *
14.3 ± 0.9 16.7 ± 1.0 23.6 ± 0.7*
< 5.0 < 5.0 < 5.0
21.6 ± 6.4 24.6 ± 4.6 42.8 ± 3.3*
251 ± 34 265 ± 37 262 ± 42
1.7 ± 0.06 1.9 ± 0.11 2.2 ± 0.15*
127 ± 10 131 ± 8 160 ± 12*
6.3 ± 0.2* 6.2 ± 0.2 6.1 ± 0.1
ost, and LoBAG – Pre with LoBAG – Post.







215± 5.7 214 ± 6.3 215± 5.6 215 ± 6.3
Kg 97.6 97.2 97.2 97.2
Kg Fat-Free Mass (n = 8)
DEXA 63± 2 62 ± 2 64± 2 64 ± 2
3H2O 63± 2 63 ± 3 67 ± 2 68 ± 2
Bioelectric
Impedance
74 ± 2 72 ± 2 74± 2 74 ± 2
Creatinine
Excretion **
61 ± 3 58 ± 2 61± 3 73 ± 4*
CT Scan (cm2) (n = 7)
Visceral
Abdominal Fat
275± 23 249 ± 23 264± 22 247 ± 25
Total Abdominal
Fat
504± 41 460 ± 40 492± 42 456 ± 45
Right Thigh Fat 71 ± 10 67 ± 9 71± 11 75 ± 12
Left Thigh Fat 70 ± 10 64 ± 7 68± 10 71 ± 11
Right Thigh
Muscle
167± 8 165 ± 8 168± 9 168 ± 9
Left Thigh Muscle 162± 8 162 ± 8 164± 9 164 ± 10
Values are Mean ± SEM.
* P = 0.0009.
** Method of Forbes and Bruining [23].
Table 4 Protein (Nitrogen) Balance
Ingested Metabolized % Metab
g Nitrogen g Protein g Nitrogen g Protein
A Calculated Computer Tables Measured Calculated
Control Pre 17.0 94.2 ± 5.1 16.0 ± 1.0 88.5 94
Control Post 17.7 98.0 ± 5.0 16.9 ± 1.1 93.5 96
LoBAG Pre 17.7 98.2 ± 4.0 18.1 ± 1.3 100.1 102
LoBAG Post 35.4 195.9 ± 10.8 26.5 ± 11 146.5 75
LoBAG Post* 31.3 195.9 ± 10.8 26.5 ± 11 165.6 85
Ingested Metabolized % Metab
g Nitrogen g Protein g Nitrogen g Protein
B Measured Calculated Measured Calculated
Control Pre 17.4 ± 0.9 96.2 20.1 ± 1.3 112.2 116
Control Post 18.1 ± 0.9 100.1 21.5 ± 2.0 118.9 119
LoBAG Pre 18.1 ± 0.7 100.1 20.3 ± 1.0 112.3 112
LoBAG Post 31.8 ± 2.5 175.9 29.4 ± 1.5 162.6 92
A. Protein content of the meals was estimated using Nutritionist Pro version 2.0: (First data bank: Hearst Corporation, San Bruno, CA); Nitrogen in food was
calculated using 5.53 g protein/g N as a conversion factor [14]; *Nitrogen in food in the LoBAG post diet also was calculated using the conventional 6.25 g
protein/g N as a conversion factor, since the majority of the additional protein in the diet was animal protein (muscle); body water was calculated according to
Watson [15]; total urine nitrogen was determine by summing the urine urea nitrogen concentration,% nitrogen in creatinine (37%) and% nitrogen in uric acid
(33%). Fecal nitrogen was measured directly. The contribution of nitrogen from excreted ammonia, amino acids and hippuric acid was added as indicated in
methods.
B. Protein content of the meals was determined directly; body water was determined directly; total urine nitrogen and fecal nitrogen were determined directly
(see text for methods).
% Metabolized was calculated as g N (Metabolized/g N Ingested) × (100).
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Whether the in vivo metabolic effects of IGF-I are inde-
pendent of or depend on it being bound to carrier pro-
teins remains an unresolved issue [34].
Third, an increase in circulating total amino acid concen-
tration and specifically BCAAs stimulate protein synthesis
[9,27]. A maximal stimulation was reported to occur with
an increase in total amino acids of 2–3 fold [26]. In the
present study, the 24 hour integrated net area in the 3 con-
trols was increased 2-4 fold, and ~13 fold with a LoBAG30
diet, (>4 times that in the controls). There also was a large
increase in BCAAs, particularly leucine (12 fold) which, in
the presence of a high insulin concentration, should
strongly stimulate net protein accumulation [25,26,35], and
it was sustained for a prolonged period of time.
In contrast, an increased cortisol and glucagon concen-
tration could oppose the anabolic stimulation by insulin,
IGF-I, total and BCAAs. The 24-hour cortisol profile
remained unchanged (Figure 2). However, the 24-hour
urinary free cortisol was increased (Table 3). The latter
suggests that the free, presumably active form of circulat-
ing cortisol, could have been increased. We previously
observed an increase in urinary free cortisol in subjects
ingesting a LoBAG20 diet but this was not statistically
significant. We did not do a 24-hr serum cortisol profile
in that study [6].
We were somewhat surprised that the serum total cor-
tisol was not increased because several years ago we
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adrenocorticotropin (ACTH) when young, normal sub-
jects ingested a diet containing 4 g protein/kg body
weight over a 12-hour period in the form of 3 identical
meals [36]. A small but significant increase also occurred
when the protein content was 1 g/kg body weight. That
an increase did not occur in the present study suggests
that the protein content was not sufficient for an in-
crease to be observed, or more likely, the subjects being
older, more obese and with type 2 diabetes, do not re-
spond to an increase in dietary protein as well as do
young people without diabetes. It also is possible that a
metabolic adaptation to the increased protein content
occurred over 5 weeks. The previous study was only a
single day study. Nevertheless, a subtle increase may
have been present in the current study as indicated by
the increase in urinary free cortisol.
That the fasting glucagon concentration was un-
changed in the present study was expected. That the 24
hr integrated net and total glucagon area responses were
further elevated (5 fold and 20%, respectively) as a con-
sequence of ingestion of the LoBAG30 diet was some-
what unexpected (Figure 3). Ingestion of a LoBAG30 diet
in a previous study resulted in only a modest and not
significant further elevation in glucagon when compared
to the control diet (15% protein) [2]. However, a clearly
elevated net area response (2.6 fold) was present when
the carbohydrate content was reduced to 20% in a
LoBAG20 diet [1]. We previously reported that high
carbohydrate diets modestly decrease the circulating glu-
cagon, in normal young subjects, whereas high protein
or high fat diets greatly increased it in single day studies.
However, with the typical ratios found in the American
diet (45–55% CHO, 10-15% Pro) there generally is little
change in glucagon concentrations after meals [8,37].
An elevated glucagon concentration has been reported
to increase amino acid clearance and stimulate urea syn-
thesis, whereas a raised glucose concentration inhibits it
[38]. Thus, the metabolic disposal of the increased
absorbed amino acids derived from ingesting the LoBAG
diet could have been accelerated by the increased glucagon
concentration. The total amino acid concentration itself
also has been reported to regulate the urea synthesis rate
in a concentration-dependent fashion (reviewed in [38]).
Glucagon given as an IV bolus, also has been reported
to stimulate a transient rise in IGFBP-1 [39]. However,
even though the 24 hour net glucagon concentration
increased 5 fold in the present study (Figure 3) the
IGFBP-1 decrease was similar to that when the subjects
ingested the control diet [3].
As we have reported previously, a LoBAG30 diet
strongly stimulates an increase in insulin [1-3]. The insu-
lin concentration is further increased relative to the glu-
cose concentration. Thus, the calculated insulin resistancealso is increased. We consider this resistance to be physio-
logic and to be due to the increased protein as well as fat
content. In any regard, the increase in insulin stimulated
by protein ingestion but without a decrease in glucose into
the hypoglycemic range is important since it allows the in-
sulin to inhibit proteolysis, and thus facilitate a net in-
crease in protein synthesis stimulated by the increased
BCAAs, particularly leucine. In addition, a modest in-
crease in cortisol could induce a mild insulin-resistant
state and thus, limit the effect of insulin on glucose metab-
olism. The ingested protein-stimulated increase in gluca-
gon facilitates deamination of amino acids and urea
formation i.e. it facilitates the disposition of the remaining
amino acids [38]. The net effect is to rapidly remove from
the circulation those absorbed amino acids not removed
by the gut cells. The deaminated amino acids are largely
converted to glucose through gluconeogenesis and could
replace endogenous gluconeogenic substrates [40,41]. The
result of the entire integrated process is the amino acids
are disposed of relatively rapidly without a significant
change in plasma glucose [42-44]. Overall, it facilitates
body protein homeostasis or in the case of a LoBAG diet,
a positive nitrogen balance and an eventual possible mod-
est increase in protein mass.
Of considerable interest, even though the increase in total
serum amino acid net area response was approximately 4
fold greater when the subjects ingested a LoBAG30 diet
(Figure 2), the total amino acid concentration had returned
to the fasting baseline by the following morning indicating
complete disposal, either through metabolism (deamin-
ation) and/or from incorporation into protein.
Amino acids also can be temporarily stored in skeletal
muscle [45], but this is not likely to have been of import-
ance. It also has been reported that during the day not
only are the diet-derived amino acids oxidized but add-
itional new protein is synthesized due presumably to the
increase in insulin, BCAAs, etc. and to which an in-
crease in free IGF-I, as indicated here, could contribute.
During the night net proteolysis results in a stable pro-
tein mass [46]. This may be the case even when the pro-
tein content is increased as in the current study.
Data obtained in this and previous studies indicated
that the higher content of protein (30%) in a LoBAG diet
resulted in a relatively large calculated positive protein
balance, whereas the control diet, (55% carbohydrate,
15% protein, 30% fat), resulted in a calculated neutral
balance [6]. However, in the present study, the dietary
nitrogen was directly quantified, and not just calculated
from food tables. In addition to the urinary nitrogen
used in our calculation of protein balance, the fecal ni-
trogen also was quantified. These directly measured
results indicate that the net protein balance, as estimated
from nitrogen balance, was negative with the control
diet, but was positive with a LoBAG30 diet.
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mass and an increased risk of sarcopenia with aging has
been reported in people with type 2 diabetes [47,48].
That is, nitrogen balance is negative and greater than in
those without diabetes. However, this change in balance
would be subtle and far less than anticipated with the
negative nitrogen balance observed here.
The current data do not indicate an overall increase in
fat-free mass and presumably protein mass (Table 5).
The CT data also did not indicate an increase in muscle
mass or a reduction in thigh and abdominal fat. How-
ever, the urinary creatinine data suggest an increase in
muscle mass may have occurred [23], although not suffi-
cient for it to be detected over this time frame. Thus, a
larger and longer duration study is needed to determine
if the demonstrated positive nitrogen balance results in a
demonstrable increase in muscle mass and function.
Regarding the time duration required to observe a
change in lean mass or muscle mass, a decrease in mid
thigh muscle was determined by CT in 10 healthy men
and women (age 55–77 years) after 14 weeks on a low
protein (0.8 g/kg/day) diet [49]. Also in healthy male
subjects, Westerterp-Plantera and associates have
reported a positive protein balance and a negative fat
balance in a 4 day comparison of a 30% vs. 10% protein
diet [50]. The same group reported an increase in fat
free mass of 0.73 Kg (1.6 pounds) independent of a
change in body weight over a 3 month increased dietary
protein intervention. It also resulted in a negative fat
balance [51]. In another study, an increase in muscle
mass was observed within 4 weeks when testosterone
was administered during exercise training [52].Conclusion
The LoBAG30 diet, a high protein, low carbohydrate
diet, ingested over 5 weeks results in an in vivo meta-
bolic and hormonal milieu in which a positive protein
balance would be expected. The protein balance was
positive, but an increase in FFM was not observed. It is
possible that a subtle increase in lean body metabolizing
mass was present. Proof will require a larger and longer-
term study. In any regard, at present it is not possible to
account for the calculated and determined positive pro-
tein balance by an increase in FFM. It is possible that a
systematic analytical or calculation error is present. If so,
how this occurred is not apparent.Competing interests
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